Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin M Warren

Showing results (191-200 of 236) with videos related to

Pageof 24
Sort By:
Antimicrobial Agents and Chemotherapy|August 30, 2021
Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South AfricaZubeida Salaam-Dreyer, Elizabeth M Streicher, Frederick A Sirgel, et al.
Plos One|May 6, 2016
Mapping of Mycobacterium tuberculosis Complex Genetic Diversity Profiles in Tanzania and Other African CountriesErasto V Mbugi, Bugwesa Z Katale, Elizabeth M Streicher, et al.
Journal of Clinical Microbiology|February 16, 2022
Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort StudyHelen Cox, Galo A Goig, Zubeida Salaam-Dreyer, et al.
The Lancet. Infectious Diseases|December 18, 2018
Transmission of drug-resistant tuberculosis in HIV-endemic settingsPalwasha Y Khan, Tom A Yates, Muhammad Osman, et al.
The Lancet. Respiratory Medicine|February 19, 2020
Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy studyHridesh Mishra, Byron W P Reeve, Zaida Palmer, et al.
One Health (Amsterdam, Netherlands)|January 29, 2024
Whole genome sequencing improves the discrimination between <i>Mycobacterium bovis</i> strains on the southern border of Kruger National Park, South AfricaEduard O Roos, Johannes Loubser, Tanya J Kerr, et al.
Research Square|April 1, 2025
Oral washes and tongue swabs for Xpert MTB/RIF Ultra-based tuberculosis diagnosis in people with and without the ability to make sputumLoren Rockman, Shima Abdulgader, Stephanie Minnies, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2025
Oral washes and tongue swabs for Xpert MTB/RIF Ultra-based tuberculosis diagnosis in people with and without the ability to make sputumLoren Rockman, Shima M Abdulgader, Stephanie Minnies, et al.
The Journal of Antimicrobial Chemotherapy|July 10, 2024
The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugsMarie Wijk, Kamunkhwala Gausi, Samantha Malatesta, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2025
Efficacy and Safety of Higher Doses of Levofloxacin for MDR-TB: A Randomized Placebo-controlled Phase 2 TrialPatrick Pj Phillips, Charles A Peloquin, Timothy R Sterling, et al.
Pageof 24

Showing results (191-200 of 236) with videos related to

Sort By:
Pageof 24
Antimicrobial Agents and Chemotherapy|August 30, 2021
Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South AfricaZubeida Salaam-Dreyer, Elizabeth M Streicher, Frederick A Sirgel, et al.
Plos One|May 6, 2016
Mapping of Mycobacterium tuberculosis Complex Genetic Diversity Profiles in Tanzania and Other African CountriesErasto V Mbugi, Bugwesa Z Katale, Elizabeth M Streicher, et al.
Journal of Clinical Microbiology|February 16, 2022
Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort StudyHelen Cox, Galo A Goig, Zubeida Salaam-Dreyer, et al.
The Lancet. Infectious Diseases|December 18, 2018
Transmission of drug-resistant tuberculosis in HIV-endemic settingsPalwasha Y Khan, Tom A Yates, Muhammad Osman, et al.
The Lancet. Respiratory Medicine|February 19, 2020
Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy studyHridesh Mishra, Byron W P Reeve, Zaida Palmer, et al.
One Health (Amsterdam, Netherlands)|January 29, 2024
Whole genome sequencing improves the discrimination between <i>Mycobacterium bovis</i> strains on the southern border of Kruger National Park, South AfricaEduard O Roos, Johannes Loubser, Tanya J Kerr, et al.
Research Square|April 1, 2025
Oral washes and tongue swabs for Xpert MTB/RIF Ultra-based tuberculosis diagnosis in people with and without the ability to make sputumLoren Rockman, Shima Abdulgader, Stephanie Minnies, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2025
Oral washes and tongue swabs for Xpert MTB/RIF Ultra-based tuberculosis diagnosis in people with and without the ability to make sputumLoren Rockman, Shima M Abdulgader, Stephanie Minnies, et al.
The Journal of Antimicrobial Chemotherapy|July 10, 2024
The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugsMarie Wijk, Kamunkhwala Gausi, Samantha Malatesta, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2025
Efficacy and Safety of Higher Doses of Levofloxacin for MDR-TB: A Randomized Placebo-controlled Phase 2 TrialPatrick Pj Phillips, Charles A Peloquin, Timothy R Sterling, et al.
Pageof 24